On-demand education
eUROGEN webinar: Genetics of ARM
Dr. Sajjad Rahnama'i explains neurogenic detrusor overactivity
The infertile male in front of a therapeutic dilemma: Surgery or assisted reproductive technology (ART)
Dr. Richard Cathomas about Immunotherapy in muscle-invasive bladder cancer
Prof. Nicolas Mottet about the changes in the 2022 guidelines for prostate cancer - Part 2
New insights in treatment of bladder cancer: From localised to metastatic diseases
Prof. Nicolas Mottet about the changes in the 2022 guidelines for prostate cancer - Part 1
Laparoscopy
Megaureter – A focus on patient selection and long-term care
Heat-Free robotic treatment of Benign Prostatic Obstruction – from vision to reality?
Prof Daniel Engeler discusses important aspects in the diagnosis and treatment of Chronic Pelvic Pain
Advanced Prostate Cancer – Non-Metastatic Hormone-Sensitive Prostate Cancer (nmHSPC)
PARP inhibitors in prostate cancer. Part 2
Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments
Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice